Latest news

Today, 4:55 PM

https://twitter.com/megtirrell/status/1509270391038038024

4 minute read

50 Biggest Movers From Yesterday

Today, 4:55 PM

Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) shares gained 81.3% to close at $2.32 on Monday. Last week, AMC Entertainment Holdings purchased a major stake in Hycroft Mining Holding.

ALRN

1 minute read

Amylyx Shares Plummet On Skeptical FDA Adcomm Docs On ALS Drug

By Vandana Singh

Today, 4:55 PM

The FDA released its briefing documents for the advisory committee to discuss Amylyx Pharmaceuticals Inc’s (NASDAQ:AMLX) sodium phenylbutyrate/taurursodiol (AMX0035) powder for amyotrophic…

1 minute read

Amylyx Pharma Press Release Confirms Posting Of FDA Briefing Docs Ahead Of FDA AdCom Meeting ON Its AMX0035

Today, 4:55 PM

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) (“Amylyx” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) posted briefing documents for the March 30, 2022 Peripheral

2 minute read

Mid-Morning Market Update: Markets Mixed; SAIC Profit Tops Views

Today, 4:55 PM

U.S. stocks traded mixed this morning, with the Dow dropping around 100 points on Monday.

1 minute read

Amylyx Pharma Shares Volatile Over Last Few Mins. Following Circulation Of FDA Briefing Docs Ahead Of FDA Meeting On Co.’s Peripheral, Central Nervous System Drugs Panel

Today, 4:55 PM

https://www.fda.gov/advisory-committees/peripheral-and-central-nervous-system-drugs-advisory-committee/updated-meeting-time-and-open-public-hearing-time-march-30-2022-meeting-peripheral-and-central#event-materials

4 minute read

The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More

By Shanthi Rexaline

Today, 4:55 PM

Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets.

ADMP

2 minute read

Amylyx Pharma Highlights Launch Of US Expanded Access Program For Its AMX0035

Today, 4:55 PM

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) (“Amylyx” or the “Company”) announced today the launch of an Expanded Access Program (EAP) for AMX0035 (sodium phenylbutyrate [PB] and taurursodiol

6 minute read

80 Biggest Movers From Yesterday

Today, 4:55 PM

Gainers

ALBO

4 minute read

50 Stocks Moving In Tuesday’s Mid-Day Session